U.S. PHARMACOPEIA

Search USP29  
Ketamine Hydrochloride Injection
» Ketamine Hydrochloride Injection is a sterile solution of Ketamine Hydrochloride in Water for Injection. It contains an amount of ketamine hydrochloride (C13H16ClNO·HCl) equivalent to not less than 95.0 percent and not more than 105.0 percent of the labeled amount of ketamine (C13H16ClNO).
Packaging and storage— Preserve in single-dose or in multiple-dose containers, preferably of Type I glass, protected from light and heat.
Identification—
A: The UV absorption spectrum, measured in the region between 250 and 350 nm, of a dilution of Injection in 0.01 N methanolic sodium hydroxide containing ketamine hydrochloride equivalent to about 800 µg of ketamine per mL, exhibits maxima and minima at the same wavelengths as that of a similar preparation of USP Ketamine Hydrochloride RS, concomitantly measured.
B: The UV absorption spectrum of the solution employed for measurement of absorbance of the assay solution, prepared as directed in the Assay, exhibits maxima and minima at the same wavelengths as that of the Standard solution, prepared as directed in the Assay.
Bacterial endotoxins 85 It contains not more than 0.4 USP Endotoxin Unit per mg of ketamine hydrochloride.
pH 791: between 3.5 and 5.5.
Residual solvents 467: meets the requirements.
(Official January 1, 2007)
Other requirements— It meets the requirements under Injections 1.
Assay— Transfer an accurately measured volume of Injection, equivalent to about 500 mg of ketamine hydrochloride, to a 200-mL volumetric flask, dilute with water to volume, and mix. Transfer 20.0 mL of this solution to a 125-mL separator, add 3 mL of 0.1 N sodium hydroxide, and extract with three 15-mL portions of chloroform. Collect the chloroform extracts in a second 125-mL separator, and extract with three 30-mL portions of 0.1 N sulfuric acid, collecting the acid extracts in a 200-mL volumetric flask. Dilute with 0.1 N sulfuric acid (saturated with chloroform) to volume, and mix. Concomitantly determine the absorbances of this solution and a Standard solution of USP Ketamine Hydrochloride RS in the same medium having a known concentration of about 250 µg per mL, in 1-cm cells at the wavelength of maximum absorbance at about 269 nm, with a suitable spectrophotometer, using 0.1 N sulfuric acid (saturated with chloroform) as the blank. Calculate the quantity, in mg, of ketamine (C13H16ClNO) in each mL of the Injection taken by the formula:
(237.73 / 274.19)(2C / V)(AU / AS),
in which 237.73 and 274.19 are the molecular weights of ketamine and ketamine hydrochloride, respectively; C is the concentration, in µg per mL, of USP Ketamine Hydrochloride RS in the Standard solution; V is the volume, in mL, of Injection taken; and AU and AS are the absorbances of the solution from the Injection and the Standard solution, respectively.
Auxiliary Information— Staff Liaison : Ian DeVeau, Ph.D., Associate Director
Expert Committee : (VET05) Veterinary Drugs 05
USP29–NF24 Page 1215
Phone Number : 1-301-816-8178